Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-European Medicines Agency validates Gilead's marketing authorization application for investigational chronic hepatitis C therapy

By: Reuters: Company News
* European Medicines Agency validates Gilead's marketing authorization application for investigational chronic hepatitis c therapy sofosbuvir/velpatasvir/voxilaprevir (sof/vel/vox)
Related Stocks:
Gilead Sciences
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.